Marketing-authorisation holder · United States
CMP Dev LLC
5 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
5 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ATORVALIQ20mg/5ml · Suspension | Atorvastatin | United States | Marketed | 2023 |
| CAROSPIR25mg/5ml · Suspension | Spironolactone | United States | Marketed | 2017 |
| LIQREV10mg base/ml · Suspension | Sildenafil | United States | Not marketed | 2023 |
| NORLIQVA1mg base/ml · Solution | Amlodipine | United States | Marketed | 2022 |
| TADLIQ20mg/5ml · Suspension | Tadalafil | United States | Marketed | 2022 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past |
|---|